SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. It develops AI-based mobile commerce and engagement solutions, simplifying the purchasing process by providing relevant information and facilitating seamless transactions with a single tap. The company enables retailers, brands, and manufacturers to create dynamic connections with consumers across mobile and desktop devices. Rezolve Ai was founded in 2016 and is headquartered in London, the United Kingdom.

Rezolve AI PLC .

Rezolve AI Limited

Rezolve AI ($RZLV) is trending due to a significant rebound following a period of intense short selling and recent earnings. Community members are actively discussing the potential for a short squeeze, citing high short interest and positive analyst ratings, and celebrating the stock's resilience amid market volatility.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

ASTS is trending as investors react to the company's announcement regarding the completion of its BlueBird 6 satellite and the planned launch schedule, generating excitement about upcoming milestones. The community is buzzing with bullish sentiment, anticipating new all-time highs and significant long-term growth potential. Some traders are closely monitoring short positions and expecting a potential squeeze.

Bakkt Holdings, Inc. engages in the intersection of cryptoassets, loyalty and rewards, and payments. It also provides a platform to expand payment offerings, create new revenue streams, and increase customer loyalty. The company was founded in 2018 and is headquartered in Alpharetta, GA.

Bakkt Holdings Inc - Ordinary Shares - Class A

Bakkt Holdings Inc

BKKT is trending amid a broader crypto rally and strategic restructuring, particularly following the sale of its loyalty business and the appointment of a new board member. The community is actively discussing the potential for a short squeeze and the company's focus on digital assets, with some speculating about future partnerships and expansion. Recent corporate execution and strong year-over-year growth are also driving positive sentiment.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

CRCL is trending as traders discuss its recent price surge and potential catalysts, including unusual call buying activity and overall strength in the digital asset sector. Community members are debating whether the stock will continue its upward momentum or face profit-taking, while also weighing the impact of potential interest rate cuts on the company's revenue model. Some traders are closely watching key technical levels and potential breakout points.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase ($COIN) is trending due to significant call buying activity and a recent price surge, sparking bullish sentiment. The community is actively discussing potential price targets and the correlation with Bitcoin's movements, while also debating its valuation relative to peers like Robinhood. Some are drawing comparisons to past financial crises, adding a layer of caution to the enthusiasm.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending as the community anticipates potential ETF approvals and discusses the implications of David Schwartz stepping down as CTO.  Bullish sentiment is fueled by discussions around institutional adoption, tokenization, and cross-border payment utility, with some speculating on significant price movement.  Despite positive news, XRP struggles to break the $3 mark, leading to frustration and debate about market manipulation and future potential.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath ($PATH) is trending after announcing multiple AI partnerships with Nvidia, OpenAI, and Snowflake, sparking excitement about its leadership in agentic AI. The community is buzzing about a potential short squeeze, with some comparing PATH to competitors like $PLTR.  However, some concerns remain around the CEO's ongoing stock sales.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to community speculation around positive news, a potential short squeeze, and renewed confidence in the stock's long-term prospects. Community members are actively discussing resistance levels and potential buyout scenarios, with some highlighting the stock's undervaluation relative to its revenue. Some traders are awaiting news to confirm a sustainable uptrend.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is trending as investors discuss its potential following Keybanc's Overweight rating and price target adjustment. Community members are focused on the company's key support level, potential for growth, and anticipation of a significant move upward. The stock's relationship to the broader building products sector and management's strategy are also being closely watched.

Occidental Petroleum Corp. engages in the exploration and production of oil and natural gas. It operates through the following segments: Oil and Gas, Chemical, and Midstream and Marketing. The Oil and Gas segment explores for, develops and produces oil and condensate, natural gas liquids, and natural gas. The Chemical segment manufactures and markets basic chemicals and vinyls. The Midstream and Marketing segment purchases, markets, gathers, processes, transports and stores oil, condensate, natural gas liquids, natural gas, carbon dioxide, and power. The company was founded in 1920 and is headquartered in Houston, TX.

Occidental Petroleum Corp.

Occidental Petroleum is trending amid discussions around Berkshire Hathaway's investment moves, with some questioning the wisdom of divesting its OxyChem unit. The community is debating whether the sale strengthens OXY's focus on oil and gas or if it sacrifices diversification and a reliable cash flow stream. Investors are also weighing the impact of debt reduction and potential share buybacks against concerns about exposure to volatile oil prices.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Biomerica, Inc. (BMRA) traded nearly 26% lower on Wednesday afternoon after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.biomerica.com/news/news-details/2025/Biomerica-Announces-Reverse-Stock-Split/default.aspx">said</a> it would implement a 1-for-8 reverse stock split of the issued and outstanding shares of its common stock to increase its bid price.The stock split will be effective at 12:01 a.m. ET on April 21, and Biomerica’s common stock will begin trading on a split-adjusted basis when the market opens on Monday, the company said.Every eight shares of Biomerica’s pre-split common stock issued and outstanding will be automatically reclassified as and converted into one new share of Biomerica’s common stock, subsequently reducing the number of outstanding shares from about 20.4 million to about 2.5 million.The move is aimed at enabling the biomedical technology company to regain compliance with the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq Capital Market.To regain compliance, Biomerica’s common stock must close at or above a $1.00 per share bid price for at least ten consecutive business days prior to May 5.On Stocktwits, retail sentiment around Biomerica fell from ‘extremely bullish’ to ‘bearish’ territory over the past 24 hours while message volume rose from ‘low’ to ‘high’.<figure class="image"><img style="aspect-ratio:1306/306;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_16_at_1_33_21_PM_png_82a4f25b9a.webp" alt="BMRA's Sentiment Meter and Message Volume as of 2:00 p.m. ET on April 16, 2025 | Source: Stocktwits" width="1306" height="306"><figcaption>BMRA's Sentiment Meter and Message Volume as of 2:00 p.m. ET on April 16, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user, however, opined that today marks a good opportunity to buy the stock as the reverse split is “not that big of a deal” and the company has a strong cash runway.<stembedurl>https://stocktwits.com/ildamiano1/message/611809693</stembedurl>Biomerica’s cash and cash equivalents totaled $3.06 million as of February-end, marking an increase from $2.37 million at the end of the second quarter (Q2) of fiscal 2025.<a href="https://stocktwits.com/symbol/BMRA">BMRA stock</a> is up by about 42% year-to-date but has fallen 43% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ford-made-900-million-dollars-from-china-business-in-2024-report/chQPqv2RbOH">Ford Made $900M From China Business In 2024, Says Report: Retail Sentiment Brightens But Still Bearish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed

Every eight shares of Biomerica’s pre-split common stock issued and outstanding will be automatically reclassified as and converted into one new share of Biomerica’s common stock on Monday.

Equity

Medical diagnostic product maker Biomerica Inc. emerged as the top biotech stock with the highest jump in new retail followers on Stocktwits Friday.Shares of the nanocap company tumbled over 9% on Friday afternoon, following a 100% surge in the prior session — its best single-day performance since March 18, 2020, when the stock more than quadrupled.On Thursday, Biomerica announced that its Fortel Prostate Specific Antigen (PSA) Screening Test received approval from the UAE Ministry of Health and Prevention.&nbsp;The test offers rapid and accurate results in just 10 minutes using a simple finger-prick blood sample, measuring PSA levels, an established early marker of prostate disease.The accessible nature of the test is designed to facilitate early detection of prostate cancer and related conditions, aiming to improve patient outcomes, reduce strain on healthcare systems, and encourage proactive health management, the company said.The UAE approval aligns with Biomerica’s strategy to broaden its presence in the Middle East, a region where prostate cancer is increasingly viewed as a pressing health issue.&nbsp;The company previously achieved regional success with its EZ Detect Colon Disease At-Home Screening Test, which secured government insurance reimbursement in Dubai.Biomerica said it is working to replicate this success with the Fortel PSA test, establishing partnerships with key distributors and securing regulatory approvals to improve accessibility to early cancer detection solutions.<figure class="image"><img style="aspect-ratio:1318/324;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/BMRA_sentiment_and_message_volume_Jan_17_cec1cb6947.png" alt="BMRA sentiment and message volume Jan 17.png" width="1318" height="324"><figcaption>BMRA sentiment and message volume Jan 17 as of 11:45 am ET | source: Stocktwits</figcaption></figure>Despite Friday’s stock dip, likely driven by profit-taking, retail sentiment on Stocktwits remained ‘bullish’, with a notable rise in message volume.&nbsp;Many retail investors indicated they were “buying the dip,” as chatter about the stock soared.<stembedurl>https://stocktwits.com/chaudaaary/message/600490675</stembedurl><stembedurl>https://stocktwits.com/Gunsmoke16/message/600488437</stembedurl><stembedurl>https://stocktwits.com/543688Ireland/message/600474360</stembedurl>Biomerica’s retail follower count on Stocktwits has climbed nearly 5% over the past year, while message volume has soared over a thousand-fold, even as the stock has shed more than 31% in value during the same period.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Prostate cancer cells, 3D illustration. Prostate cancer awareness image. | Image source: KATERYNA KON/SCIENCE PHOTO LIBRARY via Getty Images

Biomerica Adds Most New Retail Followers Among Biotechs After UAE Nod For Prostate Cancer Screening Test

The latest approval aligns with Biomerica’s strategy to broaden its presence in the Middle East, a region where prostate cancer is increasingly viewed as a pressing health issue.

Biomerica, Inc. (NASDAQ:BMRA) Sees Large Decrease in Short Interest

Biomerica, Inc. (NASDAQ:BMRA  Get Free Report) saw a large decrease in short interest in March. As of March 15th, there was short interest totalling 76,700 shares, a decrease of 42.5% from the...

Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference

Collaborators at the University of Michigan will present new Data on InFoods IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE...

Biomerica (NASDAQ:BMRA) Share Price Passes Below Two Hundred Day Moving Average of $0.99

Biomerica, Inc. (NASDAQ:BMRA  Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.99 and traded as low as $0.84...

Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board

Mr. Huff was the Former CEO of LabCorp Diagnostics and joins with significant executive experience and a proven track record in medical diagnostics and healthcareIRVINE, Calif., Feb. 21, 2024...

Biomerica appoints Jack Kenny as chairman of the board

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica

Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully...

Biomerica, Inc. (NASDAQ:BMRA  Get Free Report) was the recipient of a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling...

Biomerica Reports Second Quarter 2024 Financial Results

Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to $0.09 per share from $0.12 per share...

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The firm focuses on gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates through the following geographical segments: Europe, North America, Asia, South America, and Middle East. The company was founded in September 1971 and is headquartered in Irvine, CA.

Biomerica Inc.

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$2.71
Prev Close	$2.82
Open	$2.82
Dividend Yield	0.00%
50-Day Moving Average	$3.12
Beta	0.91
Avg. Volume	392,890.95
PE Ratio	-1.30

52-Week High	$10.16
52-Week Low	$2.08
Market Capitalization	$8.09M
EPS (Annual)	-$2.16
Price to Book	1.75
Revenue Per Employee	$98,351.85
Enterprise Value/EBITDA	N/A

BMRA
Biomerica Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest BMRA News

BMRA Biomerica Inc.